reclassify Marinol (dronabinol) from Schedule II to Schedule III

The DEA is proposing to reclassify Marinol (dronabinol) from Schedule II to Schedule III.

Marinol is a synthetic form of THC...the active ingredient in marijuana. It's used for nausea or to improve appetite in patients with cancer or AIDS.

Marinol has a low potential for abuse. Its slow onset doesn't produce the same high that people get from smoking marijuana.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote